We report 14 cases of secondary myelodysplastic syndromes (sMDS) following treatment with azathioprine for non-malignant disorders. Long-term treatment with azathioprine seems to be associated with an increased risk of MDS and subsequent leukemic transformation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

treatment azathioprine
12
secondary myelodysplastic
8
myelodysplastic syndromes
8
azathioprine associated
8
syndromes treatment
4
associated aberrations
4
aberrations chromosome
4
chromosome report
4
report cases
4
cases secondary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!